ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Genetics branding: CRISPR sounds like a breakfast bar and that may be confusing – Genetic Literacy Project

Continue reading

2017-04-14 Michael Zand NEWS

Genetics branding: CRISPR sounds like a breakfast bar and that may be confusing – Genetic Literacy Project


Genetic Literacy Project

Genetics branding: CRISPR sounds like a breakfast bar and that may be confusing
Genetic Literacy Project
[D]espite massive hype in the science and general press, [the gene-editing tool CRISPR] probably remains unfamiliar or misunderstood to many people, especially those who don’t follow science news regularly. The reason might have to do with its terrible …

and more »

Continue reading

2017-04-14 Michael Zand NEWS

CRISPR goes rogue – BioEdge

BioEdgeCRISPR goes rogueBioEdgeYou know that CRISPR and gene editing have gone mainstream when they are the subjects of an airport thriller. The latest novel from New York Times bestselling author Daniel Suarez is called Change Agent and deals with sha… Continue reading

2017-04-14 Michael Zand NEWS

Theraputic Stem Cell-Sheet Transplantation May Improve Cardiomyopathy Symptoms – The Cardiology Advisor (registration)


Genetic Literacy Project

Genetics branding: CRISPR sounds like a breakfast bar and that may be confusing
Genetic Literacy Project
[D]espite massive hype in the science and general press, [the gene-editing tool CRISPR] probably remains unfamiliar or misunderstood to many people, especially those who don’t follow science news regularly. The reason might have to do with its terrible …

and more »

Continue reading

2017-04-14 Michael Zand NEWS

Cancer Immunotherapy Market Driven by Continuous Research Activities and Highly Promising Pipeline – Medgadget (blog)

Cancer Immunotherapy Market Driven by Continuous Research Activities and Highly Promising PipelineMedgadget (blog)he expanding base of patients suffering from various types of cancer has so far been the primary factor building a foundation for the glob… Continue reading

2017-04-14 Michael Zand NEWS

Lifesaving stem cell donor is finalist in health star awards – NW Evening Mail

Lifesaving stem cell donor is finalist in health star awardsNW Evening MailA LIFESAVER from Furness is a finalist in the Good Morning Britain Health Star Awards. Sean Hagan, of Askam, who saved the life of a complete stranger by donating his stem cells… Continue reading

2017-04-14 Michael Zand NEWS

Immunotherapy for glioblastoma well tolerated; survival gains observed – EurekAlert (press release)

EurekAlert (press release)Immunotherapy for glioblastoma well tolerated; survival gains observedEurekAlert (press release)DURHAM, N.C. — A phase one study of 11 patients with glioblastoma who received injections of an investigational vaccine therapy a… Continue reading

2017-04-14 Michael Zand NEWS

Immunotherapy for glioblastoma well tolerated; survival gains observed – Medical Xpress


The Cardiology Advisor (registration)

Theraputic Stem Cell-Sheet Transplantation May Improve Cardiomyopathy Symptoms
The Cardiology Advisor (registration)
HealthDay News — Stem cell-sheet transplantation shows promise in the treatment of cardiomyopathy, according to research published online in the Journal of the American Heart Association. In the new study, researchers used stem cells from the patient …
SCOTS Eye Stem Cell Study Exceeds Research GoalsEIN News (press release)

all 3 news articles »

Continue reading

2017-04-14 Michael Zand NEWS
  • 1
  • …
  • 1,846
  • 1,847
  • 1,848
  • 1,849
  • 1,850
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Medical Xpress

Immunotherapy for glioblastoma well tolerated; survival gains observed
Medical Xpress
“This is a small study, but it’s one in a sequence of clinical trials we have conducted to explore the use of an immunotherapy that specifically targets a protein on glioblastoma tumors,” said Duke’s Kristen Batich, M.D., Ph.D., lead author of a study …

and more »